Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jun;17(6):852-60.
doi: 10.1016/j.bbmt.2010.09.006. Epub 2010 Sep 18.

Iron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantation

Affiliations

Iron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantation

Philippe Armand et al. Biol Blood Marrow Transplant. 2011 Jun.

Abstract

Patients with hematologic malignancies undergoing allogeneic stem cell transplantation (HSCT) commonly have an elevated serum ferritin prior to HSCT, which has been associated with increased mortality after transplantation. This has led to the suggestion that iron overload is common and deleterious in this patient population. However, the relationship between serum ferritin and parenchymal iron overload in such patients is unknown. We report a prospective study of 48 patients with acute leukemia (AL) or myelodysplastic syndromes (MDS) undergoing myeloablative HSCT, using magnetic resonance imaging (MRI) to estimate liver iron content (LIC) and cardiac iron. The median (and range) pre-HSCT value of serum ferritin was 1549 ng/mL (20-6989); serum hepcidin, 59 ng/mL (10-468); labile plasma iron, 0 LPI units (0.0-0.9). Eighty-five percent of patients had hepatic iron overload (HIO), and 42% had significant HIO (LIC ≥5.0 mg/gdw). Only 1 patient had cardiac iron overload. There was a strong correlation between pre-HSCT serum ferritin and estimated LIC (r = .75), which was mostly dependent on prior transfusion history. Serum hepcidin was appropriately elevated in patients with HIO. Labile plasma iron elevation was rare. A regression calibration analysis supported the hypothesis that elevated pre-HSCT LIC is significantly associated with inferior post-HSCT survival. These results contribute to our understanding of the prevalence, mechanism, and consequences of iron overload in HSCT.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Distribution of pretransplantation serum ferritin and liver iron content (estimated by MRI). (A) Serum ferritin (in ng/mL); (B) Liver iron content (in mg/g dry weight).
Figure 2
Figure 2
Relationship between liver iron content, ferritin, and transfusion history. (A) Scatterplot of liver iron content (in mg/g dry weight) versus serum ferritin (in ng/mL); (B) Liver iron content versus adjusted serum ferritin (see text for details); (C) Liver iron content versus number of prior red cell units transfused. Dotted lines were fit to data using a cubic spline.

Similar articles

Cited by

References

    1. Alessandrino EP, Della Porta MG, Bacigalupo A, et al. Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study. Haematologica. 2010;95:476–484. - PMC - PubMed
    1. Altes A, Remacha AF, Sureda A, et al. Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantation. Bone Marrow Transplant. 2002;29:987–989. - PubMed
    1. Armand P, Kim HT, Cutler CS, et al. Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood. 2007;109:4586–4588. - PMC - PubMed
    1. Kataoka K, Nannya Y, Hangaishi A, et al. Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2009;15:195–204. - PubMed
    1. Lee JW, Kang HJ, Kim EK, Kim H, Shin HY, Ahn HS. Effect of iron overload and iron-chelating therapy on/allogeneic hematopoietic SCT in children. Bone Marrow Transplant. 2009;44:793–797. - PMC - PubMed

Publication types

MeSH terms